Related Experiment Video

Updated: May 27, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Wip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with

Anastasia R Goloudina1, Kan Tanoue, Arlette Hammann

  • 1Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche 866, University of Burgundy, 21078 Dijon, France.

Proceedings of the National Academy of Sciences of the United States of America
|November 9, 2011
PubMed

Insights

Wip1 phosphatase promotes apoptosis in p53-negative tumors, enhancing chemotherapy effectiveness. In normal tissues, Wip1 overexpression protects against anticancer agent-induced apoptosis, highlighting its dual role in cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • The p53 tumor suppressor pathway is frequently inactivated in cancers, contributing to therapy resistance.
  • Strategies targeting Wip1 (Wild-type p53-induced phosphatase) have been proposed for cancer treatment.

Purpose of the Study:

  • To investigate the role of Wip1 in tumors with inactivated p53.
  • To determine the effect of Wip1 modulation on cancer cells' response to chemotherapy.

Main Methods:

  • Studied Wip1 function in p53-deficient cancer models.
  • Analyzed the interaction between Wip1 and RUNX2.
  • Assessed the impact of Wip1 overexpression on chemotherapy sensitivity and apoptosis induction.

Main Results:

  • Wip1 overexpression sensitized p53-negative tumors to chemotherapeutic agents.
  • This sensitization was mediated by Wip1-RUNX2 interaction, leading to Bax induction.
  • Wip1 overexpression protected normal tissues from cisplatin-induced apoptosis.

Conclusions:

  • Wip1 phosphatase promotes apoptosis in p53-negative tumors, enhancing anticancer therapy efficacy.
  • Wip1 overexpression offers protective effects in normal tissues during chemotherapy.
  • Targeting Wip1 may require stratification based on p53 status.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...